Over the past 8–9 years, studies conducted by our group and others on these genes have uncovered two novel pathways—the C21ORF2-NEK1 and cyclin F-VCP pathways—in ALS pathogenesis, which enrich our understanding of ALS. The gene discussed is NEK1; the disease is amyotrophic lateral sclerosis.